nafoxidine has been researched along with Glomerulonephritis in 1 studies
Nafoxidine: An estrogen antagonist that has been used in the treatment of breast cancer.
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duvic, M | 1 |
| Steinberg, AD | 1 |
| Klassen, LW | 1 |
1 other study available for nafoxidine and Glomerulonephritis
| Article | Year |
|---|---|
Effect of the anti-estrogen, Nafoxidine, on NZB/W autoimmune disease.
Topics: Animals; Antibodies, Antinuclear; Autoimmune Diseases; Crosses, Genetic; DNA; Female; Glomerulonephr | 1978 |